<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02090309</url>
  </required_header>
  <id_info>
    <org_study_id>sor0237-13ctil</org_study_id>
    <nct_id>NCT02090309</nct_id>
  </id_info>
  <brief_title>Association Between Low Cortisol Levels and Whiplash Syndrome</brief_title>
  <official_title>The Association Between Low Cortisol Level and Whiplash Syndrome and the Effect of a Single Hydrocortisone Injection on Neck Symptoms Among Motor Vehicle Accident Victims: a Randomized Placebo Controlled Double Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soroka University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soroka University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesis is that low (or low relatively to the situation) cortisol levels&#xD;
      might be a causative factor of whiplash injury or post traumatic stress disorder following&#xD;
      road accidents. In this study the investigators enroll patients who sustained a road&#xD;
      accident. From all patients a blood sample will be withdrawn to measure cortisol&#xD;
      concentrations. Than, the patients will be divided into 2 groups: the study group will&#xD;
      receive a single injection of intravenous Hydrocortisone 100 milligram (a synthetic steroid&#xD;
      used routinely for many years). The control group will receive a same volume of normal saline&#xD;
      which would be used as a placebo treatment. The investigators assume that patients with low&#xD;
      cortisol levels would tend to have a higher incidence of whiplash injuries and / or post&#xD;
      traumatic stress disorders, and that a single bolus of hydrocortisone may prevent these&#xD;
      untoward sequelas of trauma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study protocol Patients arriving during day time (08:00 - 16:00) to the Soroka Hospital&#xD;
      emergency department following a motor vehicle accident and will be found eligible will be&#xD;
      asked to participate in the study. Following an informed consent the recruited patients will&#xD;
      be randomly divided into a study group or a control group. From all the participants a volume&#xD;
      of 5 milliliter of peripheral blood will be withdrawn for cortisol concentration&#xD;
      determination prior to the study intervention. After withdrawing the blood sample patients&#xD;
      will receive a single bolus of intravenous Hydrocortisone 100 milligram (study group) or&#xD;
      normal saline (0.9%) at a similar volume to that of the study drug, 5 ml (control group).&#xD;
      Patients will be otherwise receiving the regular management of a trauma patient. The enrolled&#xD;
      patients will fill simple, short questionnaires including demographic data, neck disability&#xD;
      index, (NDI), numeric pain rating scale (NPRS), Tampa scale for kinesiophobia (TSK-11), PTSD&#xD;
      questionnaire (PDA), and will be assessed by the treating physician for the degree of&#xD;
      whiplash (WAD 0-4).&#xD;
&#xD;
      The patients will be followed-up by one of the investigators for a period of 6 months. In&#xD;
      each visit the patient will be assessed again by the above mention tools.&#xD;
&#xD;
      Sample size: 45 patients in each arm. Blinding and randomization: triple blinding and using a&#xD;
      randomization software. Statistical assessment will be performed to identify differences of&#xD;
      developing WAD (whiplash associated disorder) between patients who had an admission low level&#xD;
      of cortisol compared with those who had a high or normal level, and also between patients who&#xD;
      received hydrocortisone compared to those who received placebo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevention of whiplash syndrome according to validated scales of pain and neck motion disability.</measure>
    <time_frame>Six months following the motor vehicle accident.</time_frame>
    <description>Accomplishment of the primary outcome is measured by a composite of several variables. The following indices will be used to measure the primary outcome among the enrolled patients: neck disability index, numeric pain rating scale, Tampa scale for kinesiophobia, PTSD questionnaire (PDA), and will be assessed by the treating physician for the degree of whiplash (0-4).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Injuries, Whiplash</condition>
  <arm_group>
    <arm_group_label>Hydrocortisone injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>I.V Hydrocortisone 100 mg single bolus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>I.V normal saline 0.9% a single bolus of 5 ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>100 mg IV (in the vein) injection as a single bolus of hydrocortisone for the study group.</description>
    <arm_group_label>Hydrocortisone injection</arm_group_label>
    <other_name>Cortisol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline 0.9%</intervention_name>
    <description>IV injection of 5 ml normal saline 0.9% as a single bolus.</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  victims of motor vehicle accidents&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  traumatic brain injury&#xD;
&#xD;
          -  psychiatry disorders&#xD;
&#xD;
          -  active cancerous conditions&#xD;
&#xD;
          -  adrenal diseases&#xD;
&#xD;
          -  medical treatment by estrogens, anti-depressants, melatonin, pain control.&#xD;
&#xD;
          -  substance abuse&#xD;
&#xD;
          -  hospitalization due to the trauma&#xD;
&#xD;
          -  contra indication to hydrocortisone treatment&#xD;
&#xD;
          -  over 6 hours from time of injury&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Czeiger, M.D. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soroka University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <state>Negev</state>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Czeiger, M.D</last_name>
      <email>czeiger@bgu.ac.il</email>
    </contact>
    <investigator>
      <last_name>Gad Shaked, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <state>Negev</state>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gad Shaked, M.D</last_name>
      <phone>972542365600</phone>
      <email>shakedg@bgu.ac.il</email>
    </contact>
    <contact_backup>
      <last_name>David Czeiger, M.D</last_name>
      <phone>972544761408</phone>
      <email>czeiger@bgu.ac.il</email>
    </contact_backup>
    <investigator>
      <last_name>Gad Shaked</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <state>Negev</state>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Czeiger, M.D.</last_name>
      <email>czeiger@bgu.ac.il</email>
    </contact>
    <investigator>
      <last_name>Gad Shaked</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>February 11, 2014</study_first_submitted>
  <study_first_submitted_qc>March 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2014</study_first_posted>
  <last_update_submitted>August 27, 2014</last_update_submitted>
  <last_update_submitted_qc>August 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Whiplash Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

